Fetal Monitoring Market Size, Share, and Trends 2024 to 2034

Fetal Monitoring Market (By Product: Ultrasound, Electronic Fetal Monitoring (EFM); By Method: Invasive, Non-invasive, By Portability: Portable, Non-portable; By Application: Intrapartum fetal monitoring, Antepartum fetal monitoring; By End user: Others, Hospitals and maternity hospitals, Clinics) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2034

  • Last Updated : August 2024
  • Report Code : 4074
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Fetal Monitoring Market 

5.1. COVID-19 Landscape: Fetal Monitoring Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Fetal Monitoring Market, By Product

8.1. Fetal Monitoring Market Revenue and Volume, by Product, 2024-2034

8.1.1. Ultrasound

8.1.1.1. Market Revenue and Volume Forecast (2021-2034)

8.1.2. Electronic Fetal Monitoring (EFM)

8.1.2.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 9. Global Fetal Monitoring Market, By Method

9.1. Fetal Monitoring Market Revenue and Volume, by Method, 2024-2034

9.1.1. Invasive

9.1.1.1. Market Revenue and Volume Forecast (2021-2034)

9.1.2. Non-invasive

9.1.2.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 10. Global Fetal Monitoring Market, By Portability 

10.1. Fetal Monitoring Market Revenue and Volume, by Portability, 2024-2034

10.1.1. Portable

10.1.1.1. Market Revenue and Volume Forecast (2021-2034)

10.1.2. Non-portable

10.1.2.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 11. Global Fetal Monitoring Market, By Application

11.1. Fetal Monitoring Market Revenue and Volume, by Application, 2024-2034

11.1.1. Intrapartum fetal monitoring

11.1.1.1. Market Revenue and Volume Forecast (2021-2034)

11.1.2. Antepartum fetal monitoring

11.1.2.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 12. Global Fetal Monitoring Market, By Application

12.1. Fetal Monitoring Market Revenue and Volume, by Application, 2024-2034

12.1.1. Others

12.1.1.1. Market Revenue and Volume Forecast (2021-2034)

12.1.2. Hospitals and maternity hospitals

12.1.2.1. Market Revenue and Volume Forecast (2021-2034)

12.1.3. Clinics

12.1.3.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 13. Global Fetal Monitoring Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Volume Forecast, by Product (2021-2034)

13.1.2. Market Revenue and Volume Forecast, by Method (2021-2034)

13.1.3. Market Revenue and Volume Forecast, by Portability (2021-2034)

13.1.4. Market Revenue and Volume Forecast, by Application (2021-2034)

13.1.5. Market Revenue and Volume Forecast, by Application (2021-2034)

13.1.6. U.S.

13.1.6.1. Market Revenue and Volume Forecast, by Product (2021-2034)

13.1.6.2. Market Revenue and Volume Forecast, by Method (2021-2034)

13.1.6.3. Market Revenue and Volume Forecast, by Portability (2021-2034)

13.1.6.4. Market Revenue and Volume Forecast, by Application (2021-2034)

13.1.6.5. Market Revenue and Volume Forecast, by Application (2021-2034) 

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Volume Forecast, by Product (2021-2034)

13.1.7.2. Market Revenue and Volume Forecast, by Method (2021-2034)

13.1.7.3. Market Revenue and Volume Forecast, by Portability (2021-2034)

13.1.7.4. Market Revenue and Volume Forecast, by Application (2021-2034)

13.1.7.5. Market Revenue and Volume Forecast, by Application (2021-2034)

13.2. Europe

13.2.1. Market Revenue and Volume Forecast, by Product (2021-2034)

13.2.2. Market Revenue and Volume Forecast, by Method (2021-2034)

13.2.3. Market Revenue and Volume Forecast, by Portability (2021-2034)

13.2.4. Market Revenue and Volume Forecast, by Application (2021-2034) 

13.2.5. Market Revenue and Volume Forecast, by Application (2021-2034) 

13.2.6. UK

13.2.6.1. Market Revenue and Volume Forecast, by Product (2021-2034)

13.2.6.2. Market Revenue and Volume Forecast, by Method (2021-2034)

13.2.6.3. Market Revenue and Volume Forecast, by Portability (2021-2034)

13.2.7. Market Revenue and Volume Forecast, by Application (2021-2034) 

13.2.8. Market Revenue and Volume Forecast, by Application (2021-2034) 

13.2.9. Germany

13.2.9.1. Market Revenue and Volume Forecast, by Product (2021-2034)

13.2.9.2. Market Revenue and Volume Forecast, by Method (2021-2034)

13.2.9.3. Market Revenue and Volume Forecast, by Portability (2021-2034)

13.2.10. Market Revenue and Volume Forecast, by Application (2021-2034)

13.2.11. Market Revenue and Volume Forecast, by Application (2021-2034)

13.2.12. France

13.2.12.1. Market Revenue and Volume Forecast, by Product (2021-2034)

13.2.12.2. Market Revenue and Volume Forecast, by Method (2021-2034)

13.2.12.3. Market Revenue and Volume Forecast, by Portability (2021-2034)

13.2.12.4. Market Revenue and Volume Forecast, by Application (2021-2034)

13.2.13. Market Revenue and Volume Forecast, by Application (2021-2034)

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Volume Forecast, by Product (2021-2034)

13.2.14.2. Market Revenue and Volume Forecast, by Method (2021-2034)

13.2.14.3. Market Revenue and Volume Forecast, by Portability (2021-2034)

13.2.14.4. Market Revenue and Volume Forecast, by Application (2021-2034)

13.2.15. Market Revenue and Volume Forecast, by Application (2021-2034)

13.3. APAC

13.3.1. Market Revenue and Volume Forecast, by Product (2021-2034)

13.3.2. Market Revenue and Volume Forecast, by Method (2021-2034)

13.3.3. Market Revenue and Volume Forecast, by Portability (2021-2034)

13.3.4. Market Revenue and Volume Forecast, by Application (2021-2034)

13.3.5. Market Revenue and Volume Forecast, by Application (2021-2034)

13.3.6. India

13.3.6.1. Market Revenue and Volume Forecast, by Product (2021-2034)

13.3.6.2. Market Revenue and Volume Forecast, by Method (2021-2034)

13.3.6.3. Market Revenue and Volume Forecast, by Portability (2021-2034)

13.3.6.4. Market Revenue and Volume Forecast, by Application (2021-2034)

13.3.7. Market Revenue and Volume Forecast, by Application (2021-2034)

13.3.8. China

13.3.8.1. Market Revenue and Volume Forecast, by Product (2021-2034)

13.3.8.2. Market Revenue and Volume Forecast, by Method (2021-2034)

13.3.8.3. Market Revenue and Volume Forecast, by Portability (2021-2034)

13.3.8.4. Market Revenue and Volume Forecast, by Application (2021-2034)

13.3.9. Market Revenue and Volume Forecast, by Application (2021-2034)

13.3.10. Japan

13.3.10.1. Market Revenue and Volume Forecast, by Product (2021-2034)

13.3.10.2. Market Revenue and Volume Forecast, by Method (2021-2034)

13.3.10.3. Market Revenue and Volume Forecast, by Portability (2021-2034)

13.3.10.4. Market Revenue and Volume Forecast, by Application (2021-2034)

13.3.10.5. Market Revenue and Volume Forecast, by Application (2021-2034)

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Volume Forecast, by Product (2021-2034)

13.3.11.2. Market Revenue and Volume Forecast, by Method (2021-2034)

13.3.11.3. Market Revenue and Volume Forecast, by Portability (2021-2034)

13.3.11.4. Market Revenue and Volume Forecast, by Application (2021-2034)

13.3.11.5. Market Revenue and Volume Forecast, by Application (2021-2034)

13.4. MEA

13.4.1. Market Revenue and Volume Forecast, by Product (2021-2034)

13.4.2. Market Revenue and Volume Forecast, by Method (2021-2034)

13.4.3. Market Revenue and Volume Forecast, by Portability (2021-2034)

13.4.4. Market Revenue and Volume Forecast, by Application (2021-2034)

13.4.5. Market Revenue and Volume Forecast, by Application (2021-2034)

13.4.6. GCC

13.4.6.1. Market Revenue and Volume Forecast, by Product (2021-2034)

13.4.6.2. Market Revenue and Volume Forecast, by Method (2021-2034)

13.4.6.3. Market Revenue and Volume Forecast, by Portability (2021-2034)

13.4.6.4. Market Revenue and Volume Forecast, by Application (2021-2034)

13.4.7. Market Revenue and Volume Forecast, by Application (2021-2034)

13.4.8. North Africa

13.4.8.1. Market Revenue and Volume Forecast, by Product (2021-2034)

13.4.8.2. Market Revenue and Volume Forecast, by Method (2021-2034)

13.4.8.3. Market Revenue and Volume Forecast, by Portability (2021-2034)

13.4.8.4. Market Revenue and Volume Forecast, by Application (2021-2034)

13.4.9. Market Revenue and Volume Forecast, by Application (2021-2034)

13.4.10. South Africa

13.4.10.1. Market Revenue and Volume Forecast, by Product (2021-2034)

13.4.10.2. Market Revenue and Volume Forecast, by Method (2021-2034)

13.4.10.3. Market Revenue and Volume Forecast, by Portability (2021-2034)

13.4.10.4. Market Revenue and Volume Forecast, by Application (2021-2034)

13.4.10.5. Market Revenue and Volume Forecast, by Application (2021-2034)

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Volume Forecast, by Product (2021-2034)

13.4.11.2. Market Revenue and Volume Forecast, by Method (2021-2034)

13.4.11.3. Market Revenue and Volume Forecast, by Portability (2021-2034)

13.4.11.4. Market Revenue and Volume Forecast, by Application (2021-2034)

13.4.11.5. Market Revenue and Volume Forecast, by Application (2021-2034)

13.5. Latin America

13.5.1. Market Revenue and Volume Forecast, by Product (2021-2034)

13.5.2. Market Revenue and Volume Forecast, by Method (2021-2034)

13.5.3. Market Revenue and Volume Forecast, by Portability (2021-2034)

13.5.4. Market Revenue and Volume Forecast, by Application (2021-2034)

13.5.5. Market Revenue and Volume Forecast, by Application (2021-2034)

13.5.6. Brazil

13.5.6.1. Market Revenue and Volume Forecast, by Product (2021-2034)

13.5.6.2. Market Revenue and Volume Forecast, by Method (2021-2034)

13.5.6.3. Market Revenue and Volume Forecast, by Portability (2021-2034)

13.5.6.4. Market Revenue and Volume Forecast, by Application (2021-2034)

13.5.7. Market Revenue and Volume Forecast, by Application (2021-2034)

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Volume Forecast, by Product (2021-2034)

13.5.8.2. Market Revenue and Volume Forecast, by Method (2021-2034)

13.5.8.3. Market Revenue and Volume Forecast, by Portability (2021-2034)

13.5.8.4. Market Revenue and Volume Forecast, by Application (2021-2034)

13.5.8.5. Market Revenue and Volume Forecast, by Application (2021-2034)

Chapter 14. Company Profiles

14.1. GE Healthcare

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Siemens Healthineers

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Koninklijke Philips N.V.

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. FUJIFILM SonoSite, Inc.

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. Cardinal Health, Inc.

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Nemo Healthcare

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. Mindchild Medical Inc.

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Edan Instrument Inc

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. Clinical Innovation, LLC

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. Neoventa Medical AB

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

 

16.2. Glossary of Terms

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client